Point estimation for adaptive trial designs II: practical considerations and guidance

David S. Robertson, Babak Choodari-Oskooei, Munya Dimairo +3

In adaptive clinical trials, the conventional end-of-trial point estimate of a treatment effect is prone to bias, that is, a systematic tendency to deviate from its true value. As…